![Myriam Mendila](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Myriam Mendila
Hoofd Techniek/Wetenschap/O&O bij
CUREVAC
Profiel
Myriam Mendila currently works at CureVac NV, as Chief Scientific Officer, Head-R&D.
Dr. Mendila also formerly worked at Novartis Pharma AG, as Chief Medical Officer-Oncology.
Dr. Mendila received her doctorate degree from Hannover Medical School.
Actieve functies van Myriam Mendila
| Bedrijven | Functie | Begin |
|---|---|---|
| CUREVAC | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Myriam Mendila
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | - |
Opleiding van Myriam Mendila
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
